Gynesonics, USA

Women's health


HBM contact: Dr Chandra Leo

Company status: private

Gynesonics has developed a safe and effective, incision-free treatment for uterine fibroids, the most common benign tumors in women. The Sonata System has received clearance from the Food and Drug Administration in the United States, as well as a CE mark approval for Europe. 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171